Title of the cohort
Cohort – Ankara Training and Research Hospital
Acronym for cohort
Name of Principal Investigator
Title | n/a |
First name | |
Last name |
Address of institution where award is held
Institution | n/a |
Street Address | |
City | Ankara |
Postcode |
Country
Turkey
Website
n/a
Contact email
Funding source
1. The cohort includes, or expects to include, incidence of the following conditions
- Alzheimer’s disease and other dementias
When studies on the above condition(s) are expected to become possible
2a. Stated aim of the cohort
n/a
2b. Features distinguishing this cohort from other population cohorts
3a. i) Number of publications that involve use of cohort to date
0
3a. ii) Up to three examples of studies to date (PI, Institution, Title of Study)
3b. Publication list/link to where data or publications are accessible (if available)
3c. Information (i.e. research findings) expected to be gained from the population cohort
4a. Study criteria: age range of participants at recruitment
Age in years from: | 00 |
To (‘until death’ if applicable): |
4b. Study criteria: inclusion criteria
n/a
4c. Study criteria: exclusion criteria
n/a
5. Size of the cohort (i.e. number of participants enrolled)
1,000 – 5,000 participants
6a. Measures used to characterise participants
n/a
6b. Additional measures for participants with a clinical disorder
6c. Are there defined primary and secondary endpoints (e.g. defined health parameters)
No
7. Study design
- Other (please specify)
- n/a
8. Cases matched by
- Other health assessment (specify) / N/A
- n/a
9a. Does the study include a specialised subset of control participants
No
9b. If yes, description of specialised subset of control participants
10a. i) Data collection start date
04-05-2011
10a. ii) Data collection end date
14-05-2011
10a iii) Data collection for this study is
At the planning stage
10b. Plans to continue the cohort study beyond the current projected end date
11. Data collected
12. System in place to enable re-contact with patients for future studies
13a. Format and availability of data stored in a database
Language used:
13b. Format and availability of data held as individual records
Language used:
14a. Are data available to other groups
No
14b. Access policy/mechanisms for access if data are available to other groups
- Other criteria (please specify)
- n/a
15. Data sharing policy specified as a condition of use
No policy exists
16a. Are tissues/samples/DNA available to other groups
No
16b. i) Description of available tissues/samples/DNA
16b. ii) Form available tissues/samples/DNA are supplied in
16b. iii) Is the access policy/mechanism for obtaining samples the same as that for obtaining data
17. Is information on biological characteristics available to other groups
- No